Gene Biotherapeutics, Inc. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/677b04f3-e4ed-49cf-8cec-dee78967fcc4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2013 | $894.5k | 2003-12-22 – 2014-03-31 | evidence 0001193125-14-201188 |
| FY 2012 | $59.4k | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-144256 |
| FY 2011 | $0 | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-144275 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Gene Biotherapeutics, Inc. — all facts · Net Income · Operating Income